In 2011, Anne B. Young, MD, PhD, the now-retired chief of the Neurology Service, committed $1 million in support of the MassGeneral Institute for Neurodegenerative Disease (MIND). Dr. Young’s contribution, made through a planned gift of a flexible deferred charitable gift annuity (CGA), will provide key resources for the Department of Neurology and MIND to pursue groundbreaking research that will help find new treatments for neurodegenerative disease, ensure the highest quality of care and provide educational opportunities for both junior and experienced staff.
Dr. Young is the founder and scientific director of MIND and a world-renowned expert in Huntington’s and Parkinson’s diseases. She is an established authority on the clinical diagnosis and treatment of both Parkinson’s and Huntington’s, and through MIND has spearheaded comprehensive drug discovery efforts that have been successful in identifying drug targets for Parkinson’s, Huntington’s and other neurodegenerative diseases.
On the Cusp of Finding New Treatments
Dr. Young was the first female chief of service at Mass General when she was appointed in 1991 and has been an inspiring role model for women in academic medicine. In 2000, Dr. Young became only the second woman elected president of the 127-year-old American Neurological Association (ANA), and is the only person (male or female) to have been president of both the International Society for Neuroscience and the ANA.
“We are on the cusp of finding new ways to treat Parkinson’s, Huntington’s, ALS and Alzheimer’s,” Dr. Young says, in explaining the thinking behind her gift. “I am confident that with enough resources scientists at MIND can develop new treatments that will help patients around the world who are suffering from these diseases,” Dr. Young adds. “I hope others join me in support of this cause.
“I thought that the most important thing was to try to keep all of the amazing research going forward at MIND so we can cure these diseases. I really want this place to be the hottest, coolest place to work in neurology because it’s the place where new treatments are being discovered. So that’s what my goal is. It felt really good to give that to the hospital.”